CS Paper Radar

Training-Time Domain Transfer for Generator-Free Diagnostics on Novel Modalities in Computational Pathology

Julia A. Mielcarz, Andrea Camilloni, Nita Mulliqi, Jessica A. Frank, Anders Blilie, Emilius A. M. Janssen, Martin Eklund, Kimmo Kartasalo

cs.CV cs.AI ·submitted 2026-11-02 10:59 UTC · v1
benchmark

Abstract

Novel imaging modalities promise improved diagnostics, but AI development is constrained by scarce training data. Inference-time domain transfer can address this by mapping novel modalities to established ones, enabling reuse of existing diagnostic models. However, this introduces hallucination risks, computational overhead, and regulatory complexity. Inspired by sim-to-real transfer, we propose training-time domain transfer, generating synthetic target-domain training data from archived routine samples to enable direct diagnosis on real inputs without inference-time generation. Using unstained prostate histopathology as a proof-of-concept, we compare this approach with inference-time virtual staining and conventional H&E-based cancer detection. Training-time transfer achieved higher concordance with the conventional benchmark than virtual staining for both raw (Cohen's $κ$=0.59 vs. 0.37; Gwet's AC1=0.73 vs. 0.29) and deparaffinized tissue ($κ$=0.66 vs. 0.61; AC1=0.73 vs. 0.64), supporting its potential for emerging diagnostic modalities.

Comment
4 pages, 2 figures. Submitted to IEEE ISBI 2027

Closest papers

Nearest neighbours by meaning across the whole index.

Learning Prostate Anatomy at Test Time for Cancer Detection in Micro-Ultrasound

cs.CV cs.LG ·2026-08-20 ·Obed Korshie Dzikunu, Mohammad Mahdi Abootorabi, Mohamed Harmanani, Paul F. R. Wilson, Emma Willis +5 more
code/data similarity 0.71
Abstract

Domain shift across clinical centers using different imaging hardware or acquisition protocols remains a fundamental barrier to deploying deep learning models for prostate cancer (PCa) detection. Existing test-time adaptation (TTA) methods address distribution shift through entropy minimization or augmentation-based self-supervision, correcting for statistical differences in image appearance but ignoring the anatomical structure of the target domain. We propose ANT, a segmentation-guided TTA framework that adapts a pretrained cancer detection encoder to the target domain by solving an auxiliary prostate segmentation task at test time, supervised by pseudo-masks from a frozen pretrained segmentation network. By aligning encoder representations to prostate anatomy in the target domain, ANT corrects domain-specific feature drift while preserving cancer-discriminative structure. The model was trained on 693 patients imaged with an earlier-generation micro-ultrasound scanner in a multi-center clinical trial, and evaluated on 118 patients acquired with a newer-generation system across two centers in another clinical trial. Under a leave-one-center-out protocol with identical evaluation conditions across all methods, ANT improves mean AUC by 2.9% and 3.6% at the biopsy-core and patient levels, respectively, over no adaptation, outperforming TTA baselines. Code is available at: https://github.com/ObedDzik/ant.git.

0.51

Reliability-Aware Benchmarking of Self-Supervised Learning in Histopathology Under 1-10% Label Regimes

cs.CV cs.LG ·2026-11-04 ·Alicem Koyun, Pranjali Changadeo Pingale, Sachin Mote, Gianluca Pizzuti
publishedbenchmarkcode/data similarity 0.69
Abstract · Oral presentation, CIBB 2026 (21st International Conference on Computational Intelligence Methods for Bioinformatics and Biostatistics, Rome…

Expert annotation in digital pathology is expensive, and low-label regimes remain common in realistic histopathology workflows. Self-supervised learning (SSL) offers a practical way to learn transferable representations from unlabeled pathology images, but performance-only evaluation can hide unreliable confidence behavior under domain shift. We present a reliability-aware benchmark of SimCLR, BYOL, and an MAE-inspired masked-reconstruction baseline on PatchCamelyon (PCam; 96x96) and PANDA (prostate cancer) under 1%, 5%, and 10% labeled regimes with frozen-encoder linear probing. To address common single-run concerns, ResNet-18 results are repeated over 3 splits x 3 seeds (n=9) and ViT-B/16 over 1 split x 3 seeds (n=3) under practical compute constraints, with mean+/-std reporting and per-run logs. Beyond AUROC, accuracy, and F1-score, we report Expected Calibration Error and Brier score, OOD confidence diagnostics for cross-dataset PCam<->PANDA scoring, federated-vs-centralized SimCLR comparisons on PCam, and cross-dataset transfer to colorectal histology tiles. SSL improves label efficiency on the more controlled PCam task, while PANDA's noisier patch-level proxy can remain near coin-flip with higher variance. The study highlights that histopathology SSL should be assessed not only by ranking performance but also by calibration, robustness, and transparent reproducibility diagnostics before clinical interpretation.

0.46

ProtoCouncil: Multi-Encoder Anatomical Prototypes for Prostate Cancer Detection in Micro-Ultrasound

cs.CV cs.AIcs.LG ·2026-11-06 ·Mohammad Mahdi Abootorabi, Nooshin Maghsoodi, Armin Saadat, Obed Dzikunu, Zhuoxin Guo +6 more
similarity 0.65
Abstract · 12 pages, 3 figures, Under Review

Purpose: Micro-ultrasound ($μ$US) is a promising modality for prostate cancer (PCa) detection, but identifying suspicious tissue depends heavily on clinical experience. Models trained on sparse, noisy core-level pathology offer little insight into their decisions and can fail under domain shift. Clinical use needs a traceable decision process and a flag for uncertain predictions. Methods: We introduce ProtoCouncil, in which three foundation encoders (MedSAM, DINOv3 and V-JEPA 2.1) learn case-based prototypes at three anatomical levels: whole gland, needle track and gland sectors. Prototypes are projected onto real training-core regions, and label-free fusion keeps every class logit as a bias plus an exact sum of prototype similarity contributions. Encoder disagreement triggers selective prediction. Results: In five-fold patient-level cross-validation (6,588 cores, 693 patients), ProtoCouncil reaches 82.9% AUROC for clinically significant PCa (csPCa, Grade Group $\geq$3), 4.3 points above the best previously published method. In zero-shot evaluation on two external cohorts, ProtoCouncil achieves higher all-cancer and csPCa AUROC than all previous methods. Nearest same-class exemplars match test-core tumor involvement better than random same-class cases. Externally, csPCa accuracy falls from 79% when encoders agree to 27% when two oppose the fused call. Abstaining on disagreement raises balanced accuracy by 7 and 15 points, while retaining 58% and 54% of the cores. Conclusion: ProtoCouncil grounds core-level predictions in exact similarity-based evidence from real, anatomically indexed training cases, which makes its reasoning interpretable. It achieves the highest csPCa AUROC across three cohorts and identifies unreliable predictions through encoder disagreement.

0.30

The BRIDGE dataset: paired brightfield whole-slide images of prostate core-needle biopsies in paraffin, after deparaffinization and H&E staining

cs.CV ·2026-11-10 ·Julia A. Mielcarz, Justyna Durślewicz, Marek Zdrenka, Ahmad Abbadi, Martin Eklund +3 more
dataset similarity 0.65
Abstract

Computational approaches are increasingly being explored to streamline histopathology workflows, including label-free methods that aim to reduce reliance on chemical staining. Among these, deep learning-based label-free virtual staining uses images of unstained tissue to computationally generate stained images. Despite growing interest, model development and validation remain constrained by the scarcity of paired, clinically annotated whole-slide imaging datasets. We present BRIDGE, a dataset of prostate core-needle biopsies collected at the Prof. Franciszek Lukaszczyk Oncology Centre in Bydgoszcz, Poland. The dataset comprises 869 glass slides from 169 patients, each digitized sequentially after sectioning, deparaffinization, and hematoxylin and eosin staining, yielding in total 2607 whole-slide images. The dataset supports the development and external validation of label-free virtual staining, virtual unstaining, image-registration and segmentation methods. Each slide is accompanied by a Gleason score, enabling downstream analyses of cancer classification and grading concordance. The stained images can be used independently for color normalization and cross-scanner robustness studies. All images are de-identified, distributed in their native scanner format and will be available through the BioImage Archive.

0.18

How Far from Clinical Deployment? Evaluating the Complete Unsupervised Domain Adaptation Pipeline in Medical Imaging

cs.CV cs.AI ·2026-08-12 ·Yiheng Xiong, Luisa Gallée, Daniel Santak Wolf, Heiko Hillenhagen, Michael Götz
publishedcode/data similarity 0.64
Abstract · Accepted to WACV 2027

Deploying unsupervised domain adaptation (UDA) in clinical practice requires choosing which algorithm to use and which of its trained models to ship. However, the deployment (target) domain is unlabeled, so models cannot be evaluated directly on it, leaving it unclear which to select. We address this by evaluating the complete UDA pipeline, considering both adaptation and label-free selection together. Our study covers eleven clinically relevant cross-domain scenarios from nine medical imaging datasets, with ten UDA algorithms and 13 label-free selection methods (validators), evaluating over 80,000 trained models in total. By this, we find that a capable adapted model usually exists, but identifying it without target labels is difficult: the validator-selected models leave a large and structural target performance gap to the best available one, with no evaluated validator consistently reliable. Towards closing it, we explore two strategies, ensembling and a small target-labeling budget; both narrow this gap but do not close it entirely. Overall, deployable UDA depends on the complete pipeline; addressing the less explored selection step could bring much of current UDA closer to clinical use. Our code is open sourced at \href{https://xiongyiheng.github.io/complete-uda-pipeline-site/}{Project Page}.

0.80

FedHisto-PAST: Parameter-Efficient Stain-Aware Federated Learning for Cross-Site Lung Histopathology Classification

cs.CV cs.AI ·2026-09-25 ·Muhammad Muhtasim Shahriar, M. M. Golam Hafiz, Saad Aloteibi, Mohammad Ali Moni
similarity 0.63
Abstract · Submitted to Engineering Applications of Artificial Intelligence (Elsevier)

Cross-site lung histopathology classification must account for stain variation, non-IID client data, missing classes, and the cost of adapting large pathology encoders. This study evaluates FedHisto-PAST v2 for three-way classification of adenocarcinoma (ACA), Normal, and squamous cell carcinoma (SCC). FedHisto-PAST v2 combines a frozen HIBOU-B foundation model with parameter-efficient adaptation, stain-conditioned paired-view prediction and feature consistency, reliability-aware prototype learning, and adaptive federated aggregation. Experiments used a five-client, non-IID, raw-data-local simulation with fixed internal evaluation, client-level analysis, component ablations, communication accounting, and a development-influenced exploratory LungHist700 cohort. All principal methods achieved near- ceiling internal performance, which limited discrimination on the fixed split. On LungHist700, FedHisto- PAST v2 achieved a Macro-F1 of 0.728560 and a balanced accuracy of 0.730454. Higher recognition of Normal and SCC was accompanied by lower ACA recall, and calibration remained imperfect. Prediction-level consistency was the only component with a clearly supported independent contribution in the external ablation analysis. Feature consistency and prototype regularization showed no conclusive independent overall gains in Macro-F1. The framework updated 1.253841% of the model parameters. The results provide exploratory cross-dataset evidence for stain-aware, parameter-efficient federation; they do not establish formal privacy, patient-level independence, prospective deployment, or clinical validation.

0.26

SymmAdapt: Symmetrical Flow Matching for Source-Free Domain Adaptation in Medical Image Segmentation

cs.CV ·2026-08-23 ·Tal Grossman, Noa Cahan, Hayit Greenspan
published similarity 0.62
Abstract · Accepted at SASHIMI 2026, held in conjunction with MICCAI 2026. To appear in the Springer LNCS proceedings of the MICCAI 2026 Satellite Even…

Domain shift across imaging modalities and acquisition sites remains a significant barrier to the clinical deployment of segmentation models. Source-free unsupervised domain adaptation (SFUDA) addresses this by adapting a pretrained model to an unlabeled target domain without requiring access to sensitive source data. We introduce a novel SFUDA framework built on Symmetrical Flow Matching, a unified generative model that segments an input image and synthesizes a source-like image from a mask within the same learned flow. By initializing inference from a domain-agnostic Gaussian origin, the model preserves structural consistency across domains and grounds predictions in learned anatomy rather than shifted texture statistics. Our pipeline leverages this symmetry to generate reliable pseudo-labels and corresponding source-like synthetic images from unlabeled target data, creating a generative replay buffer that anchors source knowledge during a generative self-training stage that fine-tunes on a joint set of real target and synthetic source-like images. We evaluate on abdominal multi-organ and cardiac segmentation, covering cross-modality MRI<->CT shifts, and multi-site prostate segmentation. Our approach outperforms SFUDA baselines and is competitive with conventional UDA methods.

0.25

Zero-Shot Adaptation of Medical Vision Foundation Models for High-Frequency Micro-Ultrasound Prostate Segmentation

cs.CV cs.LG ·2026-08-14 ·Ayusha Abbas, Saram Abbas, Kabita Adhikari
similarity 0.62
Abstract

Prostate cancer claims a life every 80 seconds. Early detection is needed to prevent disease progression, and both PSA density calculation and biopsy decisions rely on knowing the exact boundary of the gland. Conventional ultrasound at 6-12 MHz blurs this boundary, missing one in three high-risk cancers. Micro-ultrasound (29 MHz) improves resolution threefold but introduces dense acoustic speckle that obscures the outer wall; given the same image, two clinicians draw outlines differing by over 10% in area. Supervised methods are costly and generalise poorly across scanners. Can a foundation model segment the prostate with no training data? We present the first zero-shot pipeline for this modality: MedSAM, pre-trained on over 1.5 million medical images, localises the prostate; we then apply CLAHE to sharpen the outer wall, binary dilation to recover missed pixels, and Fourier smoothing (4 modes, s=1.05) to refine the boundary. MedSAM requires a spatial prompt, so we evaluate bounding-box and point-click strategies across 75 patients of the Micro-Ultrasound Prostate Segmentation dataset (2,621 slices). On the 20-patient held-out test set, the pipeline reduces mean boundary-distance error by 45% (Dice 0.749+/-0.043 to 0.865+/-0.029; HD95 217.2+/-36.9 to 120.1+/-26.1 px), reaching Dice 0.859 across the cohort. Its mean overlap shows no significant difference from the three non-expert rater groups (p>0.19), while segmenting 38-52% more consistently (lower inter-patient standard deviation). Point-click prompts fail regardless of placement (best Dice=0.350), because speckle gives no stable local contrast. Only an approximate bounding box is required, so any clinic can deploy it without data collection, annotation, or retraining.

0.04